(PharmaNewsWire.Com, November 26, 2019 ) The rising prevalence of end-stage renal disease (ESRD), diabetes, and hypertension is stimulating the demand for dialysis treatment in the emerging nations. Furthermore, low preference of patients for kidney transplantation, technological advancements, and substantial government healthcare expenditure on the treatment of ESRD are adding to the growth prospects of dialysis products and services market in the emerging nations.
“The peritoneal dialysis market, segmented into products and services” The peritoneal dialysis market, segmented into products and services, includes peritoneal dialysis machines, concentrates/dialysates, catheters, transfer sets, and other consumables such as tubing sets, drain bags, disconnect caps, bag connections, catheter stabilizing devices, and ports.
“The market in Asia is expected to grow at a higher rate during the forecast period (2015-2020)” On the basis of region, the dialysis market in emerging nations is segmented into India, Asia (excluding India), and the MENA region. The market in Asia is expected to grow at a higher rate during the forecast period (2015-2020). This high growth is predominantly driven by the growing number of dialysis centers, low preference for kidney transplantation, rising awareness about renal diseases, development of low-cost products, and increasing focus of dialysis firms on the Asian market. The Indian dialysis market is expected to witness a lucrative CAGR during the forecast period due to the growing patient base, government focus on providing low-cost dialysis treatment and promoting the indigenous manufacturing of dialysis products, and the growing adoption of home dialysis treatment in the country.
Recent Developments • As of December 2015, Fresenius Medical Care has provided dialysis treatment to 294,381 patients through its 3,418 dialysis clinics in major geographic regions, including Asia-Pacific (India and China) and MENA. • Baxter China partnered with the Chinese National Institute of Hospital Administration in April 2013 under an endorsement from the Ministry of Health to develop and deploy a sustainable care and delivery model named Flying Angel for peritoneal dialysis (PD) patients living in rural areas of the country.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
